PhD, Biomedicine (Epidemiology)
MPH, Public Health
Pompeu Fabra University, Barcelona, Spain
MPharm, Pharmacy
University of Barcelona, Barcelona, Spain
Maria Foraster Pulido (scientific name: Maria Foraster) works in the development of postauthorisation safety studies, among others. Dr. Foraster has research experience in pharmacoepidemiology and in the environmental determinants of cardiovascular and mental health, neurodevelopment, pregnancy outcomes and immunology, with over 100 peer-reviewed publications. She has lead and participated in multiple epidemiological studies, including international collaborative projects, and has worked with diverse stakeholders, study designs like cohort studies, and data sources. Dr. Foraster has previously worked as assistant research professor and lead epidemiologist at the Barcelona Institute for Global Health (Spain) in projects funded by the European Horizon 2020, Health Effects Institute (United States) and AXA Research Fund (France), and as a postdoctoral scientist at the Swiss Tropical and Public Health Institute (Switzerland). She has also been a scientific adviser for the World Health Organization and Spanish government and a European councilor with the International Society for Environmental Epidemiology. Dr. Foraster also cofounded the Pharmacotherapy, Genomics and Exposomics research group at University Ramon Llull (Spain) and was associate professor of Epidemiology and Public Health at the same university for 7 years.